Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$12.00 CAD
Change Today +0.11 / 0.93%
Volume 823.0
COM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 3:58 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William L. Hunter M.D., Msc, BSc

Chief Executive Officer, President and Director, Cardiome Pharma Corp.
AgeTotal Calculated CompensationThis person is connected to 27 board members in 4 different organizations across 5 different industries.

See Board Relationships
51C$1,642,236
As of Fiscal Year 2014

Background*

Dr. William L. Hunter, also known as Bill, MD, M.Sc., has been the Chief Executive Officer and President at Cardiome Pharma Corp. since July 2012. Dr. Hunter serves as a Member of Angiotech Pharmaceuticals Inc.'s scientific and management teams. He serves as Senior Advisor of Bml Canada Limited and Rosetta Capital Limited, Investment Arm, and Advisor at Bioscience Managers Pty Ltd. He founded Angiotech Pharmaceuticals Inc. in 1992 and served as its Chief Executive Officer ...

Read Full Background

Corporate Headquarters*

1441 CREEKSIDE DRIVE
Vancouver, British Columbia V6J 4S7

Canada

Phone: 604-677-6905
Fax: 604-677-6915

Board Members Memberships*

Director
Non-executive Director
2004-2011
Former Director
2004-N/A
Former Chairman
2006-N/A
Former Independent Director and Member of Compensation Committee
2006-N/A
Former Director
2007-Present
Chief Executive Officer, President and Director
2009-N/A
Director and Chairperson of Corporate Governance & Nominating Committee
2012-N/A
Non Executive Director
2014-Present
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

MS 1989
University Of British Columbia
MD 1992
University Of British Columbia
BS 1985
McGill University

Other Affiliations*

Annual Compensation*

SalaryC$650,000
Total Annual CompensationC$650,000

Stock Options*

Total Value of OptionsC$3,697,000
Total Number of Options506,000

Total Compensation*

Total Annual Cash CompensationC$1,170,000
Total Short Term CompensationC$650,000
Total Calculated CompensationC$1,642,236
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COM:CN C$12.00 CAD +0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Albert David Friesen Ph.D.Founder, Chairman and Chief Executive Officer
Medicure Inc.
C$105.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOME PHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.